Chronic, active Epstein-Barr virus infection

Area of Science:

• Virology
• Immunology
• Infectious Diseases

Background:

• Chronic active Epstein-Barr virus (EBV) infection is a rare complication of EBV, distinct from acute infectious mononucleosis.
• In this condition, the normally balanced lifelong EBV infection is disturbed, leading to potential waxing/waning or severe illness.
• The precise mechanisms causing this imbalance are not fully understood but likely involve complex interactions between host immunity and viral factors.

Purpose of the Study:

• To summarize the understanding of chronic active EBV infection, including its pathogenesis and clinical presentation.
• To review the known immunological and viral factors contributing to the disease.
• To discuss current and emerging treatment strategies for this challenging condition.

Main Methods:

• Review of existing literature on chronic active EBV infection.
• Analysis of reported immunological defects in affected patients.
• Examination of studies on viral gene expression in chronic active EBV infection.

Main Results:

• Chronic active EBV infection is characterized by a perturbed host-virus equilibrium.
• Subtle immunologic defects and enhanced viral gene expression are observed in some patients.
• Treatment remains challenging, but novel approaches are emerging.

Conclusions:

• The pathogenesis of chronic active EBV infection is heterogeneous, involving host and viral elements.
• Understanding these factors is crucial for developing effective therapies.
• Promising new treatments include etoposide-based regimens and adoptive transfer of EBV-specific cytotoxic T lymphocytes.